Navigation Links
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
Date:5/13/2013

HAYWARD, Calif., May 13, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended March 31st, 2013.

First Quarter 2013 Financial Results:

Loss from operations, which included a non-recurring and non-cash charge of approximately $1.5 million in stock-based compensation, was $6.9 million for the first quarter of 2013, compared to $20.1 million for the first quarter of 2012.  The decrease in loss from operations primarily resulted from a decrease in research and development expenses to $4.9 million from $17.7 million and a decrease in general and administrative expenses from $2.3 million to $2.0 million.  The decrease in research and development expenses in the first quarter of 2013 compared to the first quarter of 2012 was primarily the result of decreased direct and indirect clinical study costs as the Company focuses on the development of blisibimod for systemic lupus erythematosus, or lupus, and IgA nephropathy, an orphan disease.  The Company also experienced lower manufacturing spending as manufacturing of blisibimod for patient dosing in the on-going clinical studies was completed in 2012.  The decrease in general and administrative expenses for the first quarter of 2013 compared to the first quarter of 2012 was primarily due to reduced spending on consulting and professional services and reflects the Company's ongoing cost reduction efforts.

Net loss for the quarter ended March 31, 2013 was $7.6 million, or $0.06 loss per basic and diluted share, compared with loss of $20.9 million, or $0.51 loss per basic and diluted share for the quarter ended March 31, 2012. The decrease in net loss per basic and diluted share in the first quarter of 2013 as compared to the first quarter of 2012 was primarily the result
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
2. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
3. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
5. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
6. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
7. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
8. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
9. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
11. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... COLLEGE PARK, Md. , Nov. 21, 2014 /PRNewswire-USNewswire/ ... Engineering today will host the ceremonial groundbreaking of the ... Maryland, College Park. The new building will cultivate transformative ... human health.  Taking place at 10:00 a.m. ... building in the Paint Branch Parking Lot, adjacent to ...
(Date:11/21/2014)... 2014  World Hemp Oil, an importer of oil ... are now offering legal, organic oil with high CBD ... grown in medical marijuana states. People suffering from epileptic ... Parkinson,s, MS, and spinal cord injury, no longer have ... imported CBD Oil Is legal in all states. ...
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
Breaking Medicine Technology:University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
... Sept. 8 BHR Pharma, LLC ... 3, multi-center pivotal trial ( www.synapse-trial.com ) to evaluate ... a neuroprotective agent for treating severe traumatic brain injury (TBI) patients ... approximately 1,200 patients with severe (Glasgow Coma Scale scores of 4-8), ...
... , , University ... drive up high blood pressure, raise risk of heart attack , ... known that measures such as exercise, a healthy diet and not smoking ... Michigan Health System have determined the very air we breathe can be ...
Cached Medicine Technology:BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury 2Inhaling a Heart Attack: How Air Pollution Can Cause Heart Disease 2Inhaling a Heart Attack: How Air Pollution Can Cause Heart Disease 3
(Date:11/21/2014)... say they,ve mapped the genome -- the genetic "blueprint" -- ... hopes it might help others with this very rare infection. ... Biology , the tapeworm was removed from the brain of ... is so rare worldwide and completely unexpected in this country ... was pulled out from the brain," study lead author Hayley ...
(Date:11/21/2014)... 2014 Center for Autism and Related ... Insurance Funding for Autism Workshops” to help parents of ... through the insurance coverage process. Parents will learn ... the most effective ways to access coverage. The first ... 6-8:00 p.m. at 331 Montvale Ave., 5th Floor in ...
(Date:11/21/2014)... Big Bud Farms announced today that they ... with Ed Begley Jr., airing via Discovery Channel 2nd ... Bud Farms, growers of legal medical marijuana, provide the ... medical marijuana. , This segment of Innovations takes a ... products for medicating. Viewers will learn about the resources ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Launched today ... (ECA) is an all-in-one senior care coordination tool designed ... loved ones simple and intuitive for family members and ... care centers). Now, the family caregiver or home health ... daily activities, health data, medical records, goals, schedules, and ...
(Date:11/21/2014)... Lauderdale, Florida (PRWEB) November 21, 2014 ... for chronic headaches and other jaw-related symptoms, ... patients seeking relief from chronic head pain, neck pain, ... , “This year we have seen a 52% ... treated. Our network of over 300 doctors and their ...
Breaking Medicine News(10 mins):Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Comprehensive Senior Care Application Launched on Apple App Store 2Health News:National Rise In Patients Seeking Headache Relief 2
... ... Universities in Italy, in conjunction with a team of ... long research study confirming that Pecorino Romano Cheese contains high amounts ... found in certain food groups. The study reveals that even ...
... ... kids to make healthy decisions. , ... (Vocus) March 24, 2010 -- To help kids to make healthy decisions, MVP Health ... on Facebook., , , , ,“Being on Facebook enables KidPower to actually connect with families ...
... higher fees, increased utilization and more sophisticated and costly ... (HealthDay News) -- Nearly half of Americans are "extremely" ... and health insurance, and a majority place the blame ... Interactive/HealthDay poll finds. , The poll was conducted in ...
... A Guarantee Youll ... Provo, UT, March ... new 90 day risk-free offer in the United States to try Tahitian Noni bioactive beverages ... amount of product for 90 days, then they can get their full purchase price refunded back ...
... US ... organization. , ... March 24, 2010 -- This year, US Wellness is proud to earn COLA’s highest ... exemplary application of the principles of laboratory practices., , ,This is the third consecutive ...
... ... and with celebrity appeal, generating success in a difficult economy. , ... (PRWEB) March 24, 2010 -- The ... celebrities., , ,Leeza Gibbons, popular entertainment personality and National Spokesperson for ZERONA, has proven ...
Cached Medicine News:Health News:Say Cheese! New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:MVP Health Care Takes KidPower Youth Sports Program to Facebook 2Health News:Poll Finds Americans Blame Insurers, Drug Companies for Rising Health Costs 2Health News:Poll Finds Americans Blame Insurers, Drug Companies for Rising Health Costs 3Health News:Poll Finds Americans Blame Insurers, Drug Companies for Rising Health Costs 4Health News:Noni For 90 Offer Made By Tahitian Noni International 2Health News:US Wellness, Inc. Receives National Recognition for Laboratory Excellence 2Health News:Leeza Gibbons and ZERONA Equals a Winning Combination 2
... important diagnostic tool ... of a patient's ... important when deciding ... for patients receiving ...
The Karl Storz Videoscope offers maximum image quality and can be used in combination with standard documentation units. In contrast with conventional flexible endoscopes, images are displayed with ...
Maximum brightness, durability, universal power suply, microprocessor-controlled light output and, in the event of lamp failure or degredation, automatic switchover to an integraged spare lamp....
Integrated electronics, single-chip CCD camera with PAL and NTSC output. PAL output at 460 lines, NTSC output at 470 lines. 30mm focal length. 90mm length x 20mm diameter....
Medicine Products: